Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sudhir Tauro
Observed names:
S Tauro,
S. Tauro,
Tauro, S,
Tauro, S.,
Tauro, Sudhir
Institutions:
University of Dundee,
Ninewells Hospital
Observed institutions:
University Hospitals Birmingham NHS Foundation Trust,
University College London Hospitals NHS Foundation Trust,
University of Dundee,
Queen Elizabeth Hospital Birmingham,
Ninewells Hospital,
University College London
show all 6
ORCID:
0000-0002-7236-970X
Observed ORCID:
0000-0002-7236-970X
OpenAlex ID:
A5089680722
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
2012
·
Peter L. Greenberg
, Heinz Tuechler
, et al.
·
Blood
·
3,181
PDF
Clinical and biological implications of driver mutations in myelodysplastic syndromes
2013
·
Elli Papaemmanuil
, Moritz Gerstung
, et al.
·
Blood
·
1,832
SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
2011
·
E. Papaemmanuil
, M. Cazzola
, et al.
·
New England Journal of Medicine
·
1,223
PDF
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
2011
·
Luca Malcovati
, Elli Papaemmanuil
, et al.
·
Blood
·
498
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers
2005
·
Mark Cobbold
, Naeem Khan
, et al.
·
The Journal of Experimental Medicine
·
480
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo
2014
·
Petter S. Woll
, Una Kjällquist
, et al.
·
Cancer Cell
·
322
PDF
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
2020
·
Luca Malcovati
, Kristen Stevenson
, et al.
·
Blood
·
298
PDF
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
2019
·
Detlef Haase
, Kristen E. Stevenson
, et al.
·
Leukemia
·
259
PDF
Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia
2005
·
Sudhir Tauro
, Charles Craddock
, et al.
·
Journal of Clinical Oncology
·
224
PDF
Time-dependent changes in mortality and transformation risk in MDS
2016
·
Michael Pfeilstöcker
, Heinz Tuechler
, et al.
·
Blood
·
179
PDF
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)
2015
·
M G Della Porta
, H Tuechler
, et al.
·
Leukemia
·
135
PDF
Δ160p53 is a novel N‐terminal p53 isoform encoded by Δ133p53 transcript
2010
·
Virginie Marcel
, Stéphane Perrier
, et al.
·
FEBS Letters
·
132
Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee
2015
·
Rafael Bejar
, Elli Papaemmanuil
, et al.
·
Blood
·
100
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia
2009
·
C. Craddock
, S. Nagra
, et al.
·
Haematologica
·
86
PDF
Biology and management of relapsed acute myeloid leukaemia
2005
·
Charles Craddock
, Sudhir Tauro
, et al.
·
British Journal of Haematology
·
72
Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation
2004
·
K Raj
, S Narayanan
, et al.
·
Bone Marrow Transplantation
·
52
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes
2016
·
Peter L. Greenberg
, Heinz Tuechler
, et al.
·
Blood
·
51
PDF
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations
2024
·
Nigel H. Russell
, Charlotte Wilhelm-Benartzi
, et al.
·
Journal of Clinical Oncology
·
49
Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes
2002
·
S Tauro
, MD Hepburn
, et al.
·
Leukemia
·
48
Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
2001
·
S Tauro
, M D Hepburn
, et al.
·
PubMed
·
47
Absolute SILAC-Compatible Expression Strain Allows Sumo-2 Copy Number Determination in Clinical Samples
2011
·
Ivan Matic
, Ellis G. Jaffray
, et al.
·
Journal of Proteome Research
·
44
PDF
Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6
2013
·
Stephanie F. MacCallum
, Michael J. Groves
, et al.
·
Scientific Reports
·
40
PDF
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS
2018
·
Yasushi Miyazaki
, Heinz Tuechler
, et al.
·
Leukemia Research
·
27
PDF
Telomere length is an independent prognostic marker in MDS but not in de novo AML
2017
·
Jenna Williams
, Nicole H. Heppel
, et al.
·
British Journal of Haematology
·
27
PDF
Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant
2013
·
E. Nikolousis
, S. Robinson
, et al.
·
Leukemia Research
·
27
Show more works
View as search
Works count:
106
Citation count:
9,819
H-index:
26
I10-index:
37
Year
Topic
Type
